136 related articles for article (PubMed ID: 6604836)
21. Guidewire cannulation reduces risk of post-ERCP pancreatitis and facilitates bile duct cannulation.
Artifon EL; Sakai P; Cunha JE; Halwan B; Ishioka S; Kumar A
Am J Gastroenterol; 2007 Oct; 102(10):2147-53. PubMed ID: 17581267
[TBL] [Abstract][Full Text] [Related]
22. Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial.
Tsuchiya T; Itoi T; Sofuni A; Itokawa F; Kurihara T; Ishii K; Tsuji S; Kawai T; Moriyasu F
J Hepatobiliary Pancreat Surg; 2007; 14(3):302-7. PubMed ID: 17520207
[TBL] [Abstract][Full Text] [Related]
23. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent.
Sofuni A; Maguchi H; Itoi T; Katanuma A; Hisai H; Niido T; Toyota M; Fujii T; Harada Y; Takada T
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1339-46. PubMed ID: 17981247
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological prevention of post-ERCP pancreatitis: the facts and the fiction.
Testoni PA
JOP; 2004 Jul; 5(4):171-8. PubMed ID: 15254345
[No Abstract] [Full Text] [Related]
25. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography.
Schneider J; Barkin J
Gastrointest Endosc; 1997 May; 45(5):447-8. PubMed ID: 9165340
[No Abstract] [Full Text] [Related]
26. Incidence, risk factors, and prevention of post-ERCP pancreatitis.
Cooper ST; Slivka A
Gastroenterol Clin North Am; 2007 Jun; 36(2):259-76, vii-viii. PubMed ID: 17533078
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic stent prophylaxis of post endoscopic retrograde cholangiopancreatography pancreatitis: spontaneous migration rates and clinical outcomes.
Chahal P; Baron TH; Petersen BT; Topazian MD; Gostout CJ; Levy MJ
Minerva Gastroenterol Dietol; 2007 Sep; 53(3):225-30. PubMed ID: 17912184
[TBL] [Abstract][Full Text] [Related]
28. Post-ERCP pancreatitis and its prevention.
Frank CD; Adler DG
Nat Clin Pract Gastroenterol Hepatol; 2006 Dec; 3(12):680-8. PubMed ID: 17130878
[TBL] [Abstract][Full Text] [Related]
29. A randomized controlled trial of pentoxifylline for the prevention of post-ERCP pancreatitis.
Kapetanos D; Kokozidis G; Christodoulou D; Mistakidis K; Sigounas D; Dimakopoulos K; Kitis G; Tsianos EV
Gastrointest Endosc; 2007 Sep; 66(3):513-8. PubMed ID: 17725940
[TBL] [Abstract][Full Text] [Related]
30. Common bile duct investigation in patients with mild biliary pancreatitis. when and how? A prospective analysis of 48 patients.
do Amaral PC; Filho EA; Ettinger JE; Cunha AG; Cangussú HC; Lima Mde A; Fahel E
Hepatogastroenterology; 2007; 54(77):1323-5. PubMed ID: 17708246
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk.
Sherman S; Cheng CL; Costamagna G; Binmoeller KF; Puespoek A; Aithal GP; Kozarek RA; Chen YK; Van Steenbergen W; Tenner S; Freeman M; Monroe P; Geffner M; Deviere J;
Pancreas; 2009 Apr; 38(3):267-74. PubMed ID: 19214137
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis.
Madácsy L; Kurucsai G; Fejes R; Székely A; Székely I
Dig Endosc; 2009 Jan; 21(1):8-13. PubMed ID: 19691794
[TBL] [Abstract][Full Text] [Related]
33. Complications of endoscopic retrograde cholangiopancreatography.
Lal D; Lane M; Wong P
N Z Med J; 2003 Jul; 116(1177):U496. PubMed ID: 12861310
[TBL] [Abstract][Full Text] [Related]
34. Antiproteasic agents in the prevention of post-ERCP pancreatitis: rationale for use and clinical results.
Cavallini G; Frulloni L
JOP; 2003 Jan; 4(1):75-82. PubMed ID: 12555019
[No Abstract] [Full Text] [Related]
35. Serum and urine trypsinogen activation peptide in assessing post-endoscopic retrograde cholangiopancreatography pancreatitis.
Pezzilli R; Mariani A; Gabbrielli A; Morselli-Labate AM; Barassi A
Pancreas; 2010 Jan; 39(1):108-10. PubMed ID: 20019567
[No Abstract] [Full Text] [Related]
36. Hemostasis using a fully covered self-expandable metal stent for marked bleeding from the bile duct following stent removal (with videos).
Tonozuka R; Itoi T; Sofuni A; Itokawa F; Ishii K
J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):254-6. PubMed ID: 22539088
[TBL] [Abstract][Full Text] [Related]
37. Complications related to diagnostic and therapeutic endoscopic retrograde cholangiopancreatography.
Aliperti G
Gastrointest Endosc Clin N Am; 1996 Apr; 6(2):379-407. PubMed ID: 8673333
[TBL] [Abstract][Full Text] [Related]
38. ERCP in patients with periampullary diverticulum.
Rajnakova A; Goh PM; Ngoi SS; Lim SG
Hepatogastroenterology; 2003; 50(51):625-8. PubMed ID: 12828047
[TBL] [Abstract][Full Text] [Related]
39. The Prevention, recognition and treatment of post-ERCP pancreatitis.
Badalov N; Tenner S; Baillie J
JOP; 2009 Mar; 10(2):88-97. PubMed ID: 19287099
[No Abstract] [Full Text] [Related]
40. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis.
Moretó M; Zaballa M
Br J Surg; 2002 May; 89(5):628; author reply 629. PubMed ID: 12019509
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
